share_log

Medifast Analyst Ratings

Medifast Analyst Ratings

醫療快分析師評級
Benzinga ·  2023/08/09 00:23
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/08/2023 -12.72% DA Davidson $93 → $80 Maintains Neutral
07/31/2023 1.46% DA Davidson $75 → $93 Maintains Neutral
05/02/2023 -22.54% DA Davidson $94 → $71 Maintains Neutral
02/22/2023 2.55% DA Davidson $106 → $94 Maintains Neutral
11/04/2022 15.64% DA Davidson $278 → $106 Downgrades Buy → Neutral
08/04/2022 203.29% DA Davidson $352 → $278 Maintains Buy
08/04/2022 63.65% Jefferies $345 → $150 Downgrades Buy → Hold
06/02/2022 284.03% DA Davidson $341 → $352 Maintains Buy
02/24/2022 272.03% DA Davidson $349 → $341 Maintains Buy
11/08/2021 280.75% DA Davidson $395 → $349 Maintains Buy
05/05/2021 330.94% DA Davidson $302 → $395 Maintains Buy
02/26/2021 229.48% DA Davidson $239 → $302 Maintains Buy
01/25/2021 189.11% Jefferies $205 → $265 Upgrades Hold → Buy
01/12/2021 160.75% DA Davidson $205 → $239 Maintains Buy
11/05/2020 123.65% DA Davidson $180 → $205 Upgrades Neutral → Buy
06/25/2020 78.92% B. Riley Securities → $164 Initiates Coverage On → Buy
05/06/2020 -6.17% DA Davidson $83 → $86 Maintains Neutral
02/27/2020 -9.45% DA Davidson $74 → $83 Maintains Neutral
11/08/2019 -19.27% DA Davidson $250 → $74 Downgrades Buy → Neutral
07/25/2019 41.83% Jefferies → $130 Initiates Coverage On → Buy
02/27/2019 135.65% Sidoti & Co. $211 → $216 Maintains Buy
11/08/2018 Sidoti & Co. Upgrades Neutral → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023/08/08 -12.72% 達·戴維森 $93→$80 維護 中性
07/31/2023 1.46% 達·戴維森 $75→$93 維護 中性
05/02/2023 -22.54% 達·戴維森 $94→$71 維護 中性
02/22/2023 2.55% 達·戴維森 $106→$94 維護 中性
11/04/2022 15.64% 達·戴維森 $278→$106 評級下調 購買→中性
08/04/2022 203.29% 達·戴維森 $352→$278 維護
08/04/2022 63.65% 傑富瑞 $345→$150 評級下調 購買→Hold
06/02/2022 284.03% 達·戴維森 $341→$352 維護
02/24/2022 272.03% 達·戴維森 $349→$341 維護
11/08/2021 280.75% 達·戴維森 $395→$349 維護
05/05/2021 330.94% 達·戴維森 $302→$395 維護
02/26/2021 229.48% 達·戴維森 $239→$302 維護
2021/01/25 189.11% 傑富瑞 $205→$265 升級 持有→購買
2021/12/01 160.75% 達·戴維森 $205→$239 維護
11/05/2020 123.65% 達·戴維森 $180→$205 升級 中性→購買
06/25/2020 78.92% B.萊利證券 →$164 開始承保 →購買
05/06/2020 -6.17% 達·戴維森 $83→$86 維護 中性
02/27/2020 -9.45% 達·戴維森 $74→$83 維護 中性
2019年8月11日 -19.27% 達·戴維森 $250→$74 評級下調 購買→中性
2019年07月25日 41.83% 傑富瑞 →$130 開始承保 →購買
2019年02月27日 135.65% 西多蒂公司 $211→$216 維護
2018/08/11 - 西多蒂公司 升級 中性→購買

What is the target price for Medifast (MED)?

Medifast(MED)的目標價格是多少?

The latest price target for Medifast (NYSE: MED) was reported by DA Davidson on August 8, 2023. The analyst firm set a price target for $80.00 expecting MED to fall to within 12 months (a possible -12.72% downside). 5 analyst firms have reported ratings in the last year.

DA Davidson於2023年8月8日報道了Medifast(紐約證券交易所代碼:MED)的最新目標價。這家分析公司將目標價定為80.00美元,預計MED將在12個月內下跌(可能下跌12.72%)。去年有5家分析公司公佈了評級。

What is the most recent analyst rating for Medifast (MED)?

Medifast(MED)的最新分析師評級是多少?

The latest analyst rating for Medifast (NYSE: MED) was provided by DA Davidson, and Medifast maintained their neutral rating.

對Medifast(紐約證券交易所代碼:MED)的最新分析師評級由DA Davidson提供,Medifast維持其中性評級。

When is the next analyst rating going to be posted or updated for Medifast (MED)?

Medifast(MED)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公開財務報表,與Medifast的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Medifast的上一次評級是在2023年8月8日提交的,因此您應該預計下一次評級將在2024年8月8日左右提供。

Is the Analyst Rating Medifast (MED) correct?

分析師對Medifast(MED)的評級正確嗎?

While ratings are subjective and will change, the latest Medifast (MED) rating was a maintained with a price target of $93.00 to $80.00. The current price Medifast (MED) is trading at is $91.66, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Medifast(MED)評級維持不變,目標價在93.00美元至80.00美元之間。Medifast目前的交易價格為91.66美元,超出了分析師的預測範圍。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論